版本:
中国

BRIEF-Insys therapeutics accepts resignation of Santosh Vetticaden, interim CEO

April 17 Insys Therapeutics Inc

* On April 11, 2017, Insys Therapeutics accepted resignation of Santosh Vetticaden, interim chief executive officer Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐